Douglas Galasko mainly investigates Alzheimer's disease, Dementia, Disease, Pathology and Degenerative disease. His Alzheimer's disease research is included under the broader classification of Internal medicine. His Dementia research includes elements of Psychiatry and Gerontology.
His Psychiatry research integrates issues from Primary progressive aphasia, Donepezil, Risk factor and Intensive care medicine. The Disease study combines topics in areas such as Developmental psychology, Severity of illness, Neuroscience and Locus. His Degenerative disease study integrates concerns from other disciplines, such as Differential diagnosis, Apolipoprotein E and Frontotemporal dementia.
His primary areas of study are Disease, Dementia, Alzheimer's disease, Internal medicine and Pathology. His work carried out in the field of Disease brings together such families of science as Neuroscience, Pediatrics and Intensive care medicine. His Dementia study combines topics in areas such as Psychiatry, Cognition and Neuropsychology.
His research integrates issues of Audiology, Clinical psychology and Cognitive decline in his study of Cognition. Douglas Galasko focuses mostly in the field of Alzheimer's disease, narrowing it down to matters related to Gerontology and, in some cases, Activities of daily living. Douglas Galasko has included themes like Endocrinology and Oncology in his Internal medicine study.
Douglas Galasko spends much of his time researching Disease, Internal medicine, Cognition, Dementia and Biomarker. His study looks at the intersection of Disease and topics like microRNA with RNA. His biological study spans a wide range of topics, including Gastroenterology, Endocrinology and Oncology.
His Cognition study also includes fields such as
The scientist’s investigation covers issues in Disease, Cognitive impairment, Dementia, Internal medicine and Neuroimaging. His study on Apolipoprotein E and Dementia with Lewy bodies is often connected to Induced pluripotent stem cell and Ectoderm as part of broader study in Disease. Douglas Galasko interconnects Cognition and Neuropsychology in the investigation of issues within Dementia.
His Cognition study deals with Audiology intersecting with Boston Naming Test and Alzheimer's disease. Particularly relevant to Cerebrospinal fluid is his body of work in Internal medicine. His studies in Neuroimaging integrate themes in fields like Alzheimer's Disease Neuroimaging Initiative and Reversion.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium
I. G. McKeith;I. G. McKeith;D. W. Dickson;J. Lowe;M. Emre.
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Bruno Dubois;Howard H. Feldman;Claudia Jacova;Steven T. DeKosky.
Lancet Neurology (2007)
Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) Report of the consortium on DLB international workshop
I. G. Mckeith;D. Galasko;K. Kosaka;E. K. Perry.
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia.
Katya Rascovsky;John R. Hodges;David Knopman;Mario F. Mendez.
Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria
Bruno Dubois;Bruno Dubois;Howard H Feldman;Claudia Jacova;Harald Hampel;Harald Hampel.
Lancet Neurology (2014)
Revising the definition of Alzheimer's disease: a new lexicon.
Bruno Dubois;Howard H. Feldman;Howard H. Feldman;Howard H. Feldman;Claudia Jacova;Jeffrey L. Cummings.
Lancet Neurology (2010)
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
Ronald C. Petersen;Ronald G. Thomas;Michael Grundman;David Bennett.
The New England Journal of Medicine (2005)
Common variants at MS4A4/MS4A6E , CD2AP , CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj;Gyungah Jun;Gary W. Beecham;Li-San Wang.
Nature Genetics (2011)
Diagnosis and management of dementia with Lewy bodies Fourth consensus report of the DLB Consortium
Ian G. McKeith;Bradley F. Boeve;Dennis W. DIckson;Glenda Halliday.
The ageing systemic milieu negatively regulates neurogenesis and cognitive function
Saul A. Villeda;Jian Luo;Kira I. Mosher;Bende Zou.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: